Maravai Lifesciences Holdings MRVI
NASDAQ MRVI
$8.02 +0.50 (+6.65%)
At close: Nov 9, 2026 · 4:00 PM EST

Maravai Lifesciences Holdings (MRVI) Return on Sales [ROS] (2020 - 2026)

Updated

Maravai Lifesciences Holdings (MRVI) posted Return on Sales [ROS] of -29.33% for Q2 2026, up 110.50 percentage points from -139.84% a year earlier but down 26.05 percentage points from the prior quarter.

Analysis

Maravai Lifesciences Holdings (MRVI) Return on Sales [ROS] (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Maravai Lifesciences Holdings was -56.08%, up 88.92 percentage points year-over-year; for FY2025, it came in at -115.89%, down 24.99 percentage points from FY2024.

  • Annual Return on Sales [ROS] has declined for four consecutive years, with a five-year change of -158.10 percentage points (FY2020 to FY2025).
  • In prior years, Maravai Lifesciences Holdings' Return on Sales [ROS] was -90.91% in FY2024 (-79.95 pp), -10.95% in FY2023 (-75.98 pp), 65.03% in FY2022 (-4.37 pp) and 69.40% in FY2021 (+27.19 pp).
  • Quarterly Return on Sales [ROS] has run from a low of -239.93% in Q3 2024 to a high of 75.87% in Q3 2021 over five years.
  • On a year-over-year basis, Return on Sales [ROS] increased in three of the last eight quarters, with an average year-over-year change of -20.95 percentage points.
  • The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q3 2025, with a gain of 141.37 percentage points; the weakest was Q3 2024, with a drop of 216.88 percentage points.
  • According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -3.28% (Q1 2026), -117.91% (Q4 2025) and -98.56% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Thermo Fisher Scientific 267.71 Bn 244.23 Bn 5.13 Bn 18.65%
2 Abbott Laboratories 191.69 Bn 165.56 Bn 7.39 Bn 10.44%
3 Danaher 166.18 Bn 145.83 Bn 3.84 Bn 19.00%
4 Intuitive Surgical 161.07 Bn 141.36 Bn 2.08 Bn 19.44%
5 Medtronic 131.65 Bn 96.90 Bn 6.34 Bn 18.08%
6 Stryker 125.25 Bn 111.44 Bn 4.25 Bn 15.86%
7 Boston Scientific 63.85 Bn 59.29 Bn 3.43 Bn 16.12%
8 Edwards Lifesciences 60.52 Bn 43.72 Bn 1.35 Bn 17.44%
9 Becton Dickinson 59.08 Bn 56.23 Bn 2.32 Bn 13.31%
10 Maravai Lifesciences Holdings 1.19 Bn 662.88 Mn 16.19 Mn -44.97%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -44.97%
Jun 30, 2026 -29.33%
Mar 31, 2026 -3.28%
Dec 31, 2025 -117.91%
Sep 30, 2025 -98.56%
Jun 30, 2025 -139.84%
Mar 31, 2025 -104.93%
Dec 31, 2024 -66.66%
Sep 30, 2024 -239.93%
Jun 30, 2024 -19.36%
Mar 31, 2024 -29.39%
Dec 31, 2023 -9.64%
Sep 30, 2023 -23.06%
Jun 30, 2023 -16.85%
Mar 31, 2023 3.21%
Dec 31, 2022 53.37%
Sep 30, 2022 61.12%
Jun 30, 2022 74.44%
Mar 31, 2022 68.51%
Dec 31, 2021 67.65%
API Access

Maravai Lifesciences Holdings Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=MRVI&period=max&api_key=YOUR_API_KEY